Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sabrina Meyfroidt, Judith Stevens, Jan De Lepeleire, Rene Westhovens, Diederik De Cock, Kristien Van der Elst, Kris Vanhaecht & Patrick Verschueren. (2015) A general practice perspective on early rheumatoid arthritis management: A qualitative study from Flanders. European Journal of General Practice 21:4, pages 231-237.
Read now
Read now
Diederik De Cock, Kristien Van der Elst, Sabrina Meyfroidt, Patrick Verschueren & René Westhovens. (2015) The optimal combination therapy for the treatment of early rheumatoid arthritis. Expert Opinion on Pharmacotherapy 16:11, pages 1615-1625.
Read now
Read now
Articles from other publishers (14)
Aislinn F. Lalor, Joanne E. Brooker, Tomas Rozbroj, Samuel L. Whittle, Catherine L. Hill, Debra Rowett, Rachelle Buchbinder & Denise A. O'Connor. (2022) Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies. Seminars in Arthritis and Rheumatism 55, pages 151988.
Crossref
Crossref
D. De Cock, E. Buckinx, S. Pazmino, D. Bertrand, V. Stouten, R. Westhovens & P. Verschueren. (2021) Belgian rheumatologists’ preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study. Rheumatology International 42:5, pages 815-823.
Crossref
Crossref
Xinping Tian, Qian Wang, Mengtao Li, Yan Zhao, Zhiyi Zhang, Cibo Huang, Yi Liu, Huji Xu, Yaolong Chen, Lijun Wu, Yin Su, Weiguo Xiao, Miaojia Zhang, Dongbao Zhao, Linyun Sun, Xiaoxia Zuo, Junqiang Lei, Xiaofeng Li & Xiaofeng Zeng. (2021) 2018 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis. Rheumatology and Immunology Research 2:1, pages 1-14.
Crossref
Crossref
Kristien Van der Elst, Patrick Verschueren, Veerle Stouten, Sofia Pazmino, An De Groef, Diederik De Cock, Johan Joly, Philip Moons & René Westhovens. (2019) Patient‐Reported Outcome Data From an Early Rheumatoid Arthritis Trial: Opportunities for Broadening the Scope of Treating to Target. Arthritis Care & Research 71:12, pages 1566-1575.
Crossref
Crossref
Patrick Verschueren, Diederik De Cock, Luk Corluy, Rik Joos, Christine Langenaken, Veerle Taelman, Frank Raeman, Isabelle Ravelingien, Klaas Vandevyvere, Jan Lenaerts, Elke Geens, Piet Geusens, Johan Vanhoof, Anne Durnez, Jan Remans, Bert Vander Cruyssen, Els Van Essche, An Sileghem, Griet De Brabanter, Johan Joly, Sabrina Meyfroidt, Kristien Van der Elst & Rene Westhovens. (2017) Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial. Annals of the Rheumatic Diseases 76:3, pages 511-520.
Crossref
Crossref
Patrick Vandormael, Patrick Verschueren, Liesbeth De Winter & Veerle Somers. (2016) cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis. Immunologic Research 65:1, pages 307-325.
Crossref
Crossref
L. M. M. Steunebrink, G. A. Versteeg, H. E. Vonkeman, P. M. ten Klooster, H. H. Kuper, T. R. Zijlstra, P. L. C. M. van Riel & M. A. F. J. van de Laar. (2016) Initial combination therapy versus step-up therapy in treatment to the target of remission in daily clinical practice in early rheumatoid arthritis patients: results from the DREAM registry. Arthritis Research & Therapy 18:1.
Crossref
Crossref
P Verschueren & R Westhovens. (2016) Separately tackling the development of erosions with denosumab: ultimately closing a gap in the treatment of patients with rheumatoid arthritis or trying too hard too late?. Annals of the Rheumatic Diseases 75:6, pages 947-949.
Crossref
Crossref
Patrick Verschueren, Diederik De Cock, Luk Corluy, Rik Joos, Christine Langenaken, Veerle Taelman, Frank Raeman, Isabelle Ravelingien, Klaas Vandevyvere, Jan Lenaerts, Elke Geens, Piet Geusens, Johan Vanhoof, Anne Durnez, Jan Remans, Bert Vander Cruyssen, Els Van Essche, An Sileghem, Griet De Brabanter, Johan Joly, Kristien Van der Elst, Sabrina Meyfroidt & Rene Westhovens. (2015) Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial. Arthritis Research & Therapy 17:1.
Crossref
Crossref
Rachelle Buchbinder, Chris Maher & Ian A. Harris. (2015) Setting the research agenda for improving health care in musculoskeletal disorders. Nature Reviews Rheumatology 11:10, pages 597-605.
Crossref
Crossref
Sabrina Meyfroidt, Marlies Hulscher, Diederik De Cock, Kristien Van der Elst, Johan Joly, René Westhovens & Patrick Verschueren. (2015) A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritis. Clinical Rheumatology 34:5, pages 861-869.
Crossref
Crossref
Sabrina Meyfroidt, Kristien Van der Elst, Diederik De Cock, Johan Joly, René Westhovens, Marlies Hulscher & Patrick Verschueren. (2015) Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritis. Patient Education and Counseling 98:3, pages 384-390.
Crossref
Crossref
P Verschueren, D De Cock, L Corluy, R Joos, C Langenaken, V Taelman, F Raeman, I Ravelingien, K Vandevyvere, J Lenaerts, E Geens, P Geusens, J Vanhoof, A Durnez, J Remans, B Vander Cruyssen, E Van Essche, A Sileghem, G De Brabanter, J Joly, S Meyfroidt, K Van der Elst & R Westhovens. (2015) Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Annals of the Rheumatic Diseases 74:1, pages 27-34.
Crossref
Crossref
Almina Kalkan, Kerstin Roback, Eva Hallert & Per Carlsson. (2014) Factors influencing rheumatologists’ prescription of biological treatment in rheumatoid arthritis: an interview study. Implementation Science 9:1.
Crossref
Crossref